Lake Street Capital Begins Coverage on OrthoPediatrics (NASDAQ:KIDS)

Research analysts at Lake Street Capital started coverage on shares of OrthoPediatrics (NASDAQ:KIDS) in a research report issued on Monday. The brokerage set a “buy” rating and a $37.00 price target on the stock. Lake Street Capital’s price objective would indicate a potential upside of 63.00% from the stock’s current price.

KIDS has been the topic of a number of other research reports. Truist Financial reduced their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating on the stock in a research report on Wednesday, March 5th. Finally, Needham & Company LLC reissued a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a report on Wednesday, March 5th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $37.20.

OrthoPediatrics Stock Down 3.9 %

KIDS opened at $22.70 on Monday. The firm has a market cap of $551.31 million, a price-to-earnings ratio of -18.46 and a beta of 1.16. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The firm’s 50-day simple moving average is $24.50 and its 200-day simple moving average is $24.97. OrthoPediatrics has a twelve month low of $21.02 and a twelve month high of $35.99.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.04. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The firm had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. During the same period in the prior year, the firm earned ($0.23) earnings per share. Equities research analysts anticipate that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

Insider Buying and Selling

In other news, General Counsel Daniel J. Gerritzen sold 5,310 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $132,006.60. Following the transaction, the general counsel now directly owns 110,767 shares in the company, valued at $2,753,667.62. This trade represents a 4.57 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Fred Hite sold 6,443 shares of OrthoPediatrics stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $160,172.98. Following the sale, the chief financial officer now directly owns 207,989 shares of the company’s stock, valued at approximately $5,170,606.54. This trade represents a 3.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 23,732 shares of company stock worth $589,978 over the last three months. 31.80% of the stock is currently owned by company insiders.

Institutional Trading of OrthoPediatrics

A number of hedge funds have recently modified their holdings of KIDS. Wellington Management Group LLP grew its holdings in OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company’s stock valued at $24,601,000 after purchasing an additional 178,078 shares during the period. Wasatch Advisors LP lifted its holdings in OrthoPediatrics by 47.2% during the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company’s stock worth $16,141,000 after acquiring an additional 223,217 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in OrthoPediatrics by 29.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company’s stock valued at $15,576,000 after acquiring an additional 152,681 shares during the period. AWM Investment Company Inc. increased its holdings in shares of OrthoPediatrics by 14.8% in the fourth quarter. AWM Investment Company Inc. now owns 516,794 shares of the company’s stock worth $11,979,000 after acquiring an additional 66,779 shares in the last quarter. Finally, Millennium Management LLC bought a new position in shares of OrthoPediatrics during the 4th quarter valued at about $9,798,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.